CCND1 and mantle cell lymphoma: In addition, specific mutations (E36K, Y44D, or C47S) in CCND1 increase cyclin D1 protein levels, causing defective proteolysis and promoting resistance to ibrutinib in MCL cell lines (Figure 1) [89].